info@neurofarmagen.com

Neurofarmagen

Advanced Pharmacogenetics for Psychiatry

NEUROFARMAGEN® IS A PRECISION MEDICINE PLATFORM FOR PSYCHIATRY

Helps to optimise drug treatment based on the patient’s genetic profile, drug interactions, lifestyle and clinical-physiological factors that influence treatment success.

 


Neurofarmagen® is performed on a saliva sample, collected through an easy and simple process.

AB-Biotics provides a kit with all the necessary material and information, both for collecting and sending the sample and for the management of the analytical request.


HOW NEUROPHARMAGEN® WORKS


Ask your doctor for Neurofarmagen®.



Easily provide a saliva sample.



We analyse the sample in the laboratory.



Results are available in less than ten working days.



The physician accesses the results and chooses the most appropriate treatment.


PRECISION MEDICINE IS HERE

Improve your quality of life with Neurofarmagen®


ASK FOR INFORMATION

¿WHICH PATIENTS MAY BENEFIT MORE FROM THE USE OF NEUROPHARMAGEN®?

NON-RESPONDERS

DRUG-INTOLERANT PATIENTS

POLYMEDICATED PATIENTS

PARTICULARLY SENSITIVE PATIENTS

DISCOVER THE ADVANTAGES OF NEUROFARMAGEN®

Higher probability of therapeutic success

Choosing the right drug safely

Specific dosage recommendation

Decreased side effects

Shortened response time

Decreases the number of visits to the specialist

START TO NOTICE THE BENEFITS

Suitable for all types of neuropsychiatric patients


ASK FOR INFORMATION

EXPERT OPINION

  • Oriental interventions
    “In adolescence, it is crucial to prescribe adequate pharmacological treatment both to avoid undesirable side effects and to achieve greater efficacy in the treatments. A good genetic profile gives us security in making therapeutic decisions at a stage of development and growth in which the brain continues to change and mature day by day. "
    Dra. Mª Jesús Rojas de la Viuda
    Psychiatrist

  • Ramón and Cajal Hospital

    Ramón y Cajal Psychiatric Hospital (Madrid):

    "We decided to change the treatment after a detailed analysis of the results in 57% of the patients studied. We also identified many patients in our sample who had at least one better treatment option within the same therapeutic group..."

    Dr. Miguel Vega
    Psychiatrist

  • Juan José López-Ibor Foundation

    "It's important to know the genetic profile when prescribing treatment for a patient with depression. That's because there are many drugs with a lot of side effects, and we don't know which one is going to work best for each patient..."

    Dra. María Inés López Ibor
    Psychiatrist

THE FIRST PHARMACOGENETIC TEST FOR PSYCHIATRY WITH PROVEN CLINICAL UTILITY

The Neurofarmagen® guided treatment improves response rates and reduces adverse effects

ASK FOR INFORMATION